Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1982 Nov;70(5):919–926. doi: 10.1172/JCI110703

Specific Binding Sites for Triiodothyronine in the Plasma Membrane of Rat Thymocytes

CORRELATION WITH BIOCHEMICAL RESPONSES

Joseph Segal 1,2,3, Sidney H Ingbar 1,2,3
PMCID: PMC370304  PMID: 6290538

Abstract

As a prerequisite to studies of whether the plasma membrane of the rat thymocyte contains specific, saturable binding sites for the thyroid hormone 3,5,3′-triiodothyronine (T3), a method was developed for the isolation of a plasma membrane fraction from these cells. As judged from both electron microscopic and marker enzyme studies, the fraction was composed principally of plasma membrane vesicles, was free of nuclear contaminants, and was only slightly contaminated with other subcellular components. At 37°C and pH 7.4, binding of [125I]T3 by the fresh membrane preparation was rapid, reaching a maximum at 5 min and then declining with time, so that by 60 min binding was virtually nil. Decreased binding with time was due to a loss of functional binding sites, but did not reflect desensitization, since the decrease in binding activity with time was independent of the presence or absence of T3. Scatchard analysis of saturation studies revealed the presence of two binding sites, one with an apparent dissociation constant (Kd) of 0.95 nM and a maximum capacity of 5.3 × 1010 sites/100 μg protein, and the other with an apparent Kd of 25 nM and a binding capacity of 1.4 × 1012 sites/100 μg protein. Measurement of the ability of several thyronine analogues to inhibit the binding of [125I]T3 revealed the following rank order of potency: l-T3 > l-T4 > d-T3 = d-T4 > l-3,5-T2 > rT3 > d,l-thyronine. Binding of T3 was inhibited by the omission of calcium from the medium or by the addition of the beta adrenergic antagonist alprenolol. As judged from studies of the lower affinity binding site, these manipulations decreased the affinity, but not the number, of binding sites for T3. The relative potencies of thyronine analogues to inhibit the binding of [125I]T3 were generally parallel to their previously reported potencies in stimulating the uptake of the sugar analogue 2-deoxy-glucose (2-DG) in intact rat thymocytes in vitro. Further, the inhibition of T3-binding produced by l-alprenolol or by excluding calcium from the medium resembled the previously reported inhibition that these manipulations produce with respect to T3-induced enhancement of 2-DG uptake. These findings suggest that the binding sites for T3 present in the plasma membrane of rat thymocytes act as functional receptors linked to the stimulation of 2-DG uptake that T3 induces in these cells.

Full text

PDF
919

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baudhuin P. Isolation of rat liver peroxisomes. Methods Enzymol. 1974;31:356–368. doi: 10.1016/0076-6879(74)31039-7. [DOI] [PubMed] [Google Scholar]
  2. Borges M., Eisenstein Z., Burger A. G., Ingbar S. H. Immunosequestration: a new technique for studying peripheral iodothyronine metabolism in vitro. Endocrinology. 1981 May;108(5):1665–1671. doi: 10.1210/endo-108-5-1665. [DOI] [PubMed] [Google Scholar]
  3. Bosmann H. B., Pike G. Z. Membrane marker enzymes: isolation, purification, and properties of 5'-nucleotidase from rat cerebellum. Biochim Biophys Acta. 1971 Feb 10;227(2):402–412. doi: 10.1016/0005-2744(71)90071-4. [DOI] [PubMed] [Google Scholar]
  4. Desai K. S., Zinman B., Steiner G., Hollenberg C. H. Effect of calcium on [125I]insulin binding to rat adipocytes. Can J Biochem. 1978 Sep;56(9):843–848. doi: 10.1139/o78-129. [DOI] [PubMed] [Google Scholar]
  5. Doljanski F., Kapeller M. Cell surface shedding--the phenomenon and its possible significance. J Theor Biol. 1976 Oct 21;62(2):253–270. doi: 10.1016/0022-5193(76)90119-3. [DOI] [PubMed] [Google Scholar]
  6. Gharbi-Chihi J., Torresani J. Thyroid hormone binding to plasma membrane preparations: studies in different thyroid states and tissues. J Endocrinol Invest. 1981 Apr-Jun;4(2):177–183. doi: 10.1007/BF03350448. [DOI] [PubMed] [Google Scholar]
  7. Gharbi J., Torresani J. High affinity thyroxine binding to purified rat liver plasma membranes. Biochem Biophys Res Commun. 1979 May 14;88(1):170–177. doi: 10.1016/0006-291x(79)91712-1. [DOI] [PubMed] [Google Scholar]
  8. Hatefi Y. Resolution of complex II and isolation of succinate dehydrogenase (EC 1.3.99.1). Methods Enzymol. 1978;53:27–35. doi: 10.1016/s0076-6879(78)53009-7. [DOI] [PubMed] [Google Scholar]
  9. Kabir S. The isolation and characterization of plasma membranes from calf thymocytes. Prep Biochem. 1978;8(2-3):155–169. doi: 10.1080/00327487808069057. [DOI] [PubMed] [Google Scholar]
  10. Kornfeld R., Siemers C. Large scale isolation and characterization of calf thymocyte plasma membranes. J Biol Chem. 1974 Feb 25;249(4):1295–1301. [PubMed] [Google Scholar]
  11. Maxfield F. R., Willingham M. C., Pastan I., Dragsten P., Cheng S. Y. Binding and mobility of the cell surface receptors for 3,3',5-triiodo-L-thyronine. Science. 1981 Jan 2;211(4477):63–65. doi: 10.1126/science.6255563. [DOI] [PubMed] [Google Scholar]
  12. McDonald J. M., Bruns D. E., Jarett L. Characterization of calcium binding to adipocyte plasma membranes. J Biol Chem. 1976 Sep 10;251(17):5345–5351. [PubMed] [Google Scholar]
  13. Mikkelsen R. B., Freerksen D. L. Calcium binding to plasma membranes from normal and SV40 transformed hamster lymphocytes. J Recept Res. 1980;1(2):239–260. doi: 10.3109/10799898009044100. [DOI] [PubMed] [Google Scholar]
  14. Minneman K. P., Hegstrand L. R., Molinoff P. B. Simultaneous determination of beta-1 and beta-2-adrenergic receptors in tissues containing both receptor subtypes. Mol Pharmacol. 1979 Jul;16(1):34–46. [PubMed] [Google Scholar]
  15. Oppenheimer J. H. Thyroid hormone action at the cellular level. Science. 1979 Mar 9;203(4384):971–979. doi: 10.1126/science.218285. [DOI] [PubMed] [Google Scholar]
  16. Pliam N. B., Goldfine I. D. High affinity thyroid hormone binding sites on purified rat liver plasma membranes. Biochem Biophys Res Commun. 1977 Nov 7;79(1):166–172. doi: 10.1016/0006-291x(77)90075-4. [DOI] [PubMed] [Google Scholar]
  17. Samuels H. H., Tsai J. S. Thyroid hormone action in cell culture: domonstration of nuclear receptors in intact cells and isolated nuclei. Proc Natl Acad Sci U S A. 1973 Dec;70(12):3488–3492. doi: 10.1073/pnas.70.12.3488. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Segal J., Ingbar S. H. A postulated mechanism for the coordinate effects of ionophore A23187 on calcium uptake and cell viability in rat thymocytes. Biochim Biophys Acta. 1982 Jan 4;684(1):7–11. doi: 10.1016/0005-2736(82)90042-6. [DOI] [PubMed] [Google Scholar]
  19. Segal J., Ingbar S. H. Direct and synergistic interactions of 3,5,3'-triiodothyronine and the adrenergic system in stimulating sugar transport by rat thymocytes. J Clin Invest. 1980 May;65(5):958–966. doi: 10.1172/JCI109782. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Segal J., Ingbar S. H. Stimulation by triiodothyronine of the in vitro uptake of sugars by rat thymocytes. J Clin Invest. 1979 Mar;63(3):507–515. doi: 10.1172/JCI109329. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Segal J., Ingbar S. H. Stimulation of 2-deoxy-D-glucose uptake in rat thymocytes in vitro by physiological concentrations of triiodothyronine, insulin, or epinephrine. Endocrinology. 1980 Nov;107(5):1354–1358. doi: 10.1210/endo-107-5-1354. [DOI] [PubMed] [Google Scholar]
  22. Segal J., Ingbar S. H. Studies of the mechanism by which 3,5,3'- triiodothyronine stimulates 2-deoxyglucose uptake in rat thymocytes in vitro. Role of calcium and adenosine 3':5'-monophosphate. J Clin Invest. 1981 Jul;68(1):103–110. doi: 10.1172/JCI110224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Spindler B. J., MacLeod K. M., Ring J., Baxter J. D. Thyroid hormone receptors. Binding characteristics and lack of hormonal dependency for nuclear localization. J Biol Chem. 1975 Jun 10;250(11):4113–4119. [PubMed] [Google Scholar]
  24. Stemerman M. B., Ross R. Experimental arteriosclerosis. I. Fibrous plaque formation in primates, an electron microscope study. J Exp Med. 1972 Oct 1;136(4):769–789. doi: 10.1084/jem.136.4.769. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Sterling K., Milch P. O., Brenner M. A., Lazarus J. H. Thyroid hormone action: the mitochondrial pathway. Science. 1977 Sep 2;197(4307):996–999. doi: 10.1126/science.196334. [DOI] [PubMed] [Google Scholar]
  26. Sterling K. Thyroid hormone action at the cell level (second of two parts). N Engl J Med. 1979 Jan 25;300(4):173–177. doi: 10.1056/NEJM197901253000405. [DOI] [PubMed] [Google Scholar]
  27. Tolone G., Bonasera L., Vitale F., Pontieri G. M. Calcium binding to mastocyte plasma membrane. Int Arch Allergy Appl Immunol. 1980;63(2):236–239. doi: 10.1159/000232631. [DOI] [PubMed] [Google Scholar]
  28. Williams L. T., Mullikin D., Lefkowitz R. J. Magnesium dependence of agonist binding to adenylate cyclase-coupled hormone receptors. J Biol Chem. 1978 May 10;253(9):2984–2989. [PubMed] [Google Scholar]
  29. van Blitterswijk W. J., Emmelot P., Feltkamp C. A. Studies on plasma membranes. XIX. Isolation and characterization of a plasma membrane fraction from calf thymocytes. Biochim Biophys Acta. 1973 Mar 29;298(3):577–592. doi: 10.1016/0005-2736(73)90075-8. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES